论文部分内容阅读
目的探讨老年慢性病患者继发性肺部真菌感染预防对策,为降低患者临床感染率提供依据。方法回顾性分析2013年9月-2014年12月医院收治的88例老年慢性病患者临床资料,将患者随机分为观察组和对照组,各44例;对照组给予常规护理和治疗,观察组患者在对照组基础上采取预防措施,对两组临床疗效进行对比分析;采用SPSS11.0软件进行统计分析。结果治疗7d后,观察组患者肺部真菌感染率为2.27%,对照组为29.55%,两组比较差异有统计学意义(P<0.05);治疗10d后,观察组临床治疗总有效率为97.73%,显著高于对照组的54.54%,两组比较差异有统计学意义(P<0.05);观察组有1例患者出现真菌耐药性,对照组有10例真菌耐药病例,两组比较差异有统计学意义(P<0.05);观察组患者住院时间和住院次数显著低于对照组患者,两组比较差异有统计学意义(P<0.05)。结论临床采取积极有效的预防措施可有效降低老年慢性病继发性肺部真菌感染率,减少患者住院时间和住院次数,提高临床疗效。
Objective To investigate the prevention and treatment of secondary pulmonary fungal infection in elderly patients with chronic diseases and to provide basis for reducing the clinical infection rate of patients. Methods The clinical data of 88 elderly patients with chronic diseases admitted from September 2013 to December 2014 in our hospital were retrospectively analyzed. The patients were randomly divided into observation group and control group, 44 cases in each group. The control group was given routine nursing care and treatment. The patients in observation group On the basis of the control group, preventive measures were taken to compare the clinical efficacy of the two groups; SPSS11.0 software was used for statistical analysis. Results After 7 days of treatment, the prevalence of pulmonary fungal infection was 2.27% in the observation group and 29.55% in the control group, with significant difference between the two groups (P <0.05). After 10 days of treatment, the total effective rate of clinical treatment in the observation group was 97.73 %, Which was significantly higher than that of the control group (54.54%), the difference between the two groups was statistically significant (P <0.05); one case in the observation group showed fungal drug resistance, and the control group had 10 cases of fungal drug resistance. (P <0.05). The length of stay and hospital stay in the observation group were significantly lower than those in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Clinical positive and effective preventive measures can effectively reduce the incidence of secondary pulmonary fungal infection in elderly patients with chronic diseases, reduce hospitalization time and hospitalization, and improve clinical efficacy.